Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn No phase listed Observational Accepts healthy volunteers

Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System

ClinicalTrials.gov ID: NCT01358799

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01358799. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 16, 2026, 10:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this multi-center clinical study is to demonstrate that the APTIMA(R) Assay for Chlamydia trachomatis (CT; "ACT Assay"), which is cleared for use on the TIGRIS DTS (Direct Transfer) System ("TIGRIS System"), can be tested on the PANTHER System. The intended use of the ACT Assay will be unchanged except for the inclusion of its use with the PANTHER System. ACT Assay performance on the PANTHER System is comparable to performance on the TIGRIS System.

Study identification

NCT ID
NCT01358799
Recruitment status
Withdrawn
Study type
Observational
Phase
Not listed
Lead sponsor
Gen-Probe, Incorporated
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
14 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2010 (Type not available)
Primary completion
Jan 2012 (Actual)
Completion
Jan 2012 (Actual)
Last update posted
Mar 12, 2013

2010 – 2012

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Wishard Health Services Department of Pathology Wishard Health Services Indianapolis Indiana 46202 —
Louisianna State University Health Center New Orleans Louisiana 92122 —
New England Center for Clinical Research Fall River Massachusetts 02720 —
University of North Carolina Chapel Hill STD Clinic Chapel Hill North Carolina 27599 —
Planned Parenthood Northeast Ohio Akron Ohio 44302 —
Cincinnati Children's Hospital Medical Center Division of Pediatric & Adolescent Gynecology Cincinnati Ohio 45229 —
Planned Parenthood Houston and Southeast Texas Houston Texas 77023 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01358799, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2013 · Synced Nov 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.